Esther Dyson - Publications and Business Ventures

Publications and Business Ventures

Currently, Dyson is a board member and active investor in a variety of start-ups, mostly in online services, health care/genetics, and space travel.

Previously, Dyson and her company EDventure specialized in analyzing the impact of emerging technologies and markets on economies and societies. She created the following publications on technology:

• Release 1.0, her monthly technology-industry newsletter, published by EDventure Holdings. Until 2006, Dyson wrote several issues herself and edited the others. When she left CNET, the newsletter was picked up by O'Reilly Media, which appointed Jimmy Guterman to edit it and renamed the newsletter Release 2.0.
• Release 2.0, her 1997 book on how the Internet affects individuals' lives. Its full title is Release 2.0: A design for living in the digital age. The revision Release 2.1 was published in 1998.
• Release 3.0, her bimonthly column for the New York Times, distributed via its syndicate and reprinted in Release 1.0 (now defunct).
• Release 4.0, her weblog. On 4 March 2005, that weblog moved to Dyson's Flickr account.

She is an occasional contributor and sits on the advisory board of a new open-access, open-source, open-peer-review journal, the Journal of Participatory Medicine.

Dyson is an adviser to the First Monday journal, and an occasional contributor to Arianna Huffington's online Huffington Post as Release 0.9.

Dyson has also been a board member or early investor in several tech startups, among them TrustedID, Cygnus Solutions, Flickr, del.icio.us, Eventful, Netbeans, Powerset, Systinet, ZEDO, CV-Online, Medscape, Medstory, Meetup, Valkee and Vurve.

As of early 2007, Dyson describes herself as "spending more and more time on private aviation and commercial space startups" and also in health care and genetics. She has invested in XCOR, Constellation Services, Zero-G, Icon Aircraft, and Space Adventures. Since 2005, she has hosted the Flight School conference in Aspen. She is currently on the board of directors of 23andMe, and is one of the first ten volunteers in the Personal Genome Project. Her latest investments include: GeriJoy., Applied Proteomics, Genomera, Habit Labs, HealthEngage, Health Loop, HealthRally, HealthTap, Keas, Lexity, Medico, Medivo, Omada Health, Organized Wisdom, PatientsLikeMe, Resilient, Tocagen, Mequibrium, VitaPortal, GreenGoose, PatientsKnowBest, and Valkee.